[go: up one dir, main page]

DK1261875T3 - Diagnostisk analyse for transmissibel spongiform encephalopati - Google Patents

Diagnostisk analyse for transmissibel spongiform encephalopati

Info

Publication number
DK1261875T3
DK1261875T3 DK01931527T DK01931527T DK1261875T3 DK 1261875 T3 DK1261875 T3 DK 1261875T3 DK 01931527 T DK01931527 T DK 01931527T DK 01931527 T DK01931527 T DK 01931527T DK 1261875 T3 DK1261875 T3 DK 1261875T3
Authority
DK
Denmark
Prior art keywords
fabp
ami
spongiform encephalopathy
diagnostic analysis
transmissible spongiform
Prior art date
Application number
DK01931527T
Other languages
English (en)
Inventor
Denis Francois Hochstrasser
Jean-Charles Sanchez
Catherine Gabrielle Zimmermann
Elisabeth Guillaume
Original Assignee
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0005683A external-priority patent/GB2360089A/en
Application filed by Univ Geneve filed Critical Univ Geneve
Application granted granted Critical
Publication of DK1261875T3 publication Critical patent/DK1261875T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/819Multifunctional antigen or antibody
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01931527T 2000-03-10 2001-03-12 Diagnostisk analyse for transmissibel spongiform encephalopati DK1261875T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0005683A GB2360089A (en) 2000-03-10 2000-03-10 Diagnostic assay for transmisible spongiform encephalopathies
GB0006064A GB0006064D0 (en) 2000-03-10 2000-03-14 Diagnostic assay for transmissable spongiform encephalopathies
PCT/EP2001/002894 WO2001067108A2 (en) 2000-03-10 2001-03-12 Diagnostic assay for transmissible spongiform encephalopathies

Publications (1)

Publication Number Publication Date
DK1261875T3 true DK1261875T3 (da) 2007-11-26

Family

ID=26243824

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01931527T DK1261875T3 (da) 2000-03-10 2001-03-12 Diagnostisk analyse for transmissibel spongiform encephalopati

Country Status (9)

Country Link
US (1) US7368247B2 (da)
EP (1) EP1261875B1 (da)
JP (1) JP4575635B2 (da)
AT (1) ATE368858T1 (da)
AU (2) AU5828201A (da)
CA (1) CA2402314C (da)
DE (1) DE60129674T2 (da)
DK (1) DK1261875T3 (da)
WO (1) WO2001067108A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US7655480B2 (en) * 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
US8450071B2 (en) 2002-03-08 2013-05-28 The Board Of Regents Of The University Of Oklahoma Biomarker and method for detecting a chronic inflammatory-associated disease
AU2003231220A1 (en) * 2002-04-30 2003-11-17 Saint Louis University A method for detecting lysosomal storage diseases
JP4279836B2 (ja) 2002-10-30 2009-06-17 プロテオメ サイエンシス ピーエルシー 牛海綿状脳症(bse)の判定方法
WO2005029088A2 (en) * 2003-09-20 2005-03-31 Electrophoretics Limited Diagnostic method for brain damage-related disorders
CN100422742C (zh) * 2005-05-16 2008-10-01 艾博(武汉)生物技术有限公司 急性心肌梗死早期诊断三合一检测试剂板
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
US7399598B2 (en) * 2005-10-14 2008-07-15 Taipei Medical University Diagnosis method of endometriosis by detecting biochemical markers and usage of these biochemical markers
US20070161074A1 (en) * 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
US7645616B2 (en) * 2006-10-20 2010-01-12 The University Of Hong Kong Use of lipocalin-2 as a diagnostic marker and therapeutic target
NL1033365C2 (nl) * 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
US9399675B2 (en) 2007-02-28 2016-07-26 The Board Of Regents Of The University Of Oklahoma Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
JP2008241387A (ja) * 2007-03-27 2008-10-09 Chube Univ メタボリックシンドロームの予知検査方法
NL2001577C2 (nl) * 2008-05-14 2009-11-17 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
KR102003258B1 (ko) 2009-12-20 2019-07-24 아스튜트 메디컬 인코포레이티드 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물
KR101458100B1 (ko) * 2012-01-13 2014-11-05 가톨릭대학교 산학협력단 류마티스 관절염 진단 키트
RU2522231C1 (ru) * 2012-11-14 2014-07-10 Евгений Иосифович Гоуфман Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
EP4105657B1 (en) 2013-01-17 2024-09-25 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11402379B2 (en) * 2016-09-09 2022-08-02 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating autoimmune GFAP astrocytopathy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3012666B2 (ja) * 1990-05-28 2000-02-28 大日本製薬株式会社 心筋梗塞の判定方法
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
GB2319607A (en) 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
EP0861900A1 (en) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
AU6894298A (en) 1997-04-08 1998-10-30 Incyte Pharmaceuticals, Inc. Human fatty acid binding protein
FR2763692B1 (fr) * 1997-05-22 1999-07-09 Agronomique Inst Nat Rech Diagnostic in vitro des encephalopathies subaigues spongiformes transmissibles, par dosage de metabolites du cortisol
CA2206774A1 (en) * 1997-06-16 1998-12-16 Rick E. Preddie "prionins", highly specific markers for noninvasive presymptomatic defection of tse diseases, and targets for therapeutic reagents to prevent and control tse diseases in animals and humans
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke

Also Published As

Publication number Publication date
JP2003526788A (ja) 2003-09-09
US20030157580A1 (en) 2003-08-21
JP4575635B2 (ja) 2010-11-04
WO2001067108A3 (en) 2002-03-21
EP1261875A2 (en) 2002-12-04
ATE368858T1 (de) 2007-08-15
DE60129674T2 (de) 2008-06-05
CA2402314A1 (en) 2001-09-13
CA2402314C (en) 2009-12-08
WO2001067108A2 (en) 2001-09-13
DE60129674D1 (de) 2007-09-13
US7368247B2 (en) 2008-05-06
AU2001258282B2 (en) 2005-05-05
AU5828201A (en) 2001-09-17
EP1261875B1 (en) 2007-08-01

Similar Documents

Publication Publication Date Title
DK1261875T3 (da) Diagnostisk analyse for transmissibel spongiform encephalopati
ATE360211T1 (de) Diagnostischer assay für schlaganfall
BR9914373A (pt) Ensaio para conformação relacionada à doença de uma proteìna.
Jensen et al. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques
Brennan et al. The utility of N, N-biotinyl glutathione disulfide in the study of protein S-glutathiolation
DE98950411T1 (de) Zusammensetzung zur Inhibierung der Proliferation glatter Muskulatur, Verfahren zur Diagnose von Arteriosklerose, sowie Kits hierzu
DK1051500T3 (da) Diagnose og behandling af AUR1- og/eller AUR2-relaterede sygdomme
ES2171705T3 (es) Complejos de polipeptido-dendrimero.
EA199800460A1 (ru) Диагностика и медиаторы воспалительных нарушений
WO2003042659A3 (en) Rapid prion-detection assay
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
SE8802944L (sv) Material foer lapptestning
EA200101021A1 (ru) Способ диагностики трансмиссивных губчатых энцефалопатий
Trimpin et al. Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
BR0206904A (pt) Métodos e dispositivos para quantificação de proteìna com glicato
FI885312L (fi) Menetelmä spesifisesti sitovan proteiinin ja vastaavan sidottavan aineen välisen reaktion yhden tai useamman komponentin määrittämiseksi koenäytteestä käyttäen ainakin yhtä leimattua komponenttia, menetelmä leimatun komponentin valmistamiseksi sekä koepakkaus.......
WO2002099434A3 (de) Verwendung von 14-3-3-proteinen und verfahren zu deren bestimmung in flüssigkeiten oder geweben von organismen
EP1311860A2 (en) Methods and kits for separation and detection of proteins in biological samples
AU2001287423A1 (en) Methods and kits for separation and detection of proteins in biological samples
Hu et al. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes
ATE110469T1 (de) Nichttrennender festphasen-enzymtest.
ATE75049T1 (de) Biologisches diagnostisches testsystem.
Schwartz et al. Novel chemiluminescent Western blot blocking and antibody incubation solution for enhanced antibody‐antigen interaction and increased specificity
Kinumi et al. Affinity-tagged phosphorylation assay by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (ATPA-MALDI): Application to calcium/calmodulin-dependent protein kinase